PortfoliosLab logo

Ayala Pharmaceuticals, Inc. (AYLA)

Equity · Currency in USD · Last updated Jun 25, 2022

Company Info

ISINUS05465V1089
CUSIP05465V108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.25
Year Range$1.24 - $14.09
EMA (50)$2.24
EMA (200)$5.90
Average Volume$64.87K
Market Capitalization$17.95M

AYLAShare Price Chart


Chart placeholderClick Calculate to get results

AYLAPerformance

The chart shows the growth of $10,000 invested in Ayala Pharmaceuticals, Inc. on May 11, 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $712 for a total return of roughly -92.88%. All prices are adjusted for splits and dividends.


AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AYLAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-42.78%-0.75%
YTD-87.43%-17.93%
6M-87.72%-17.23%
1Y-90.21%-7.78%
5Y-71.13%14.56%
10Y-71.13%14.56%

AYLAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AYLASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ayala Pharmaceuticals, Inc. Sharpe ratio is -1.15. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AYLADividend History


Ayala Pharmaceuticals, Inc. doesn't pay dividends

AYLADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AYLAWorst Drawdowns

The table below shows the maximum drawdowns of the Ayala Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ayala Pharmaceuticals, Inc. is 95.14%, recorded on Jun 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.14%Feb 17, 2021342Jun 24, 2022
-44.72%May 19, 202077Sep 4, 2020109Feb 11, 2021186
-0.99%May 12, 20201May 12, 20204May 18, 20205

AYLAVolatility Chart

Current Ayala Pharmaceuticals, Inc. volatility is 82.40%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with Ayala Pharmaceuticals, Inc.


Loading data...